Carlisle Companies Incorporated
—- Market cap
- —
- Debt
- —
- Cash
- −$1.11B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CSL stock price vs FLO: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at FLO's multiple
Needs FLO P/E.
Implied fair value · at CSL's multiple
Needs CSL P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
13 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CARLISLE COMPANIES INCORPORATED · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
FLOWERS FOODS, INC · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LyondellBasell Industries N.V.
CSL vs LYB
Celanese Corp
CSL vs CE
GOODYEAR TIRE & RUBBER CO /OH/
CSL vs GT
Avery Dennison Corp
CSL vs AVY
Garrett Motion Inc.
CSL vs GTX
Gentherm Inc
CSL vs THRM
Post Holdings, Inc.
CSL vs POST
J M SMUCKER Co
CSL vs SJM
Zoetis Inc.
CSL vs ZTS
CONAGRA BRANDS INC.
CSL vs CAG
COCA COLA CO
CSL vs KO
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CSL can sustain its 20.0% operating margin and 70.0% ROIC, then holding is reasonable, but if those quality metrics normalize, the current price looks difficult to justify because the P/E model implies 19.8% downside and the DCF range sits well below spot.
On the provided P/E valuation, CSL’s current price of $386.72 sits 19.8% above the implied price of $310.30, suggesting the stock trades richer than the model supports. The gap is partly justified by CSL’s much stronger profitability and balance sheet than FLO, but it is still a clear valuation stretch relative to the stated fair value estimate.
Supporting Metrics